These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9414180)

  • 1. Re: Researchers make slow headway in managing dry mouth.
    LeVeque F
    J Natl Cancer Inst; 1997 Dec; 89(24):1894-5. PubMed ID: 9414180
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of oral pilocarpine in xerostomia and Sjögren's syndrome.
    Nusair S; Rubinow A
    Semin Arthritis Rheum; 1999 Jun; 28(6):360-7. PubMed ID: 10406404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACR presentations support Salagen tablets as a safe and effective treatment for the dry mouth symptoms caused by Sjögren's syndrome.
    Compr Ther; 1999 Jan; 25(1):53. PubMed ID: 9987593
    [No Abstract]   [Full Text] [Related]  

  • 4. Does salivary gland scintigraphy predict response to pilocarpine in patients with post-radiotherapy xerostomia?
    Cooper RA; Cowan RA; Owens SE; Jeans SP; Roberts JK; Hillel PG; Slevin NJ; Allan E; Gupta NK; Collins CD
    Eur J Nucl Med; 1999 Mar; 26(3):220-5. PubMed ID: 10079311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic pilocarpine for treatment of xerostomia.
    Berk L
    Expert Opin Drug Metab Toxicol; 2008 Oct; 4(10):1333-40. PubMed ID: 18798702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary gland ultrasonography as a primary imaging tool for predicting efficacy of xerostomia treatment in patients with Sjögren's syndrome.
    Takagi Y; Sumi M; Nakamura H; Sato S; Kawakami A; Nakamura T
    Rheumatology (Oxford); 2016 Feb; 55(2):237-45. PubMed ID: 26338664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral pilocarpine (Salagen)--a recently approved salivary stimulant.
    Wynn RL
    Gen Dent; 1996; 44(1):26, 29-30. PubMed ID: 8940567
    [No Abstract]   [Full Text] [Related]  

  • 8. Salivary enhancement: current status and future therapies.
    Atkinson JC; Baum BJ
    J Dent Educ; 2001 Oct; 65(10):1096-101. PubMed ID: 11699983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manifestations and treatment of xerostomia and associated oral effects secondary to head and neck radiation therapy.
    Garg AK; Malo M
    J Am Dent Assoc; 1997 Aug; 128(8):1128-33. PubMed ID: 9260423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilocarpine treatment of xerostomia in head and neck patients.
    Leek H; Albertsson M
    Micron; 2002; 33(2):153-5. PubMed ID: 11567884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group.
    Vivino FB; Al-Hashimi I; Khan Z; LeVeque FG; Salisbury PL; Tran-Johnson TK; Muscoplat CC; Trivedi M; Goldlust B; Gallagher SC
    Arch Intern Med; 1999 Jan; 159(2):174-81. PubMed ID: 9927101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial saliva products and drugs to treat xerostomia.
    Wynn RL; Meiller TF
    Gen Dent; 2000; 48(6):630-6. PubMed ID: 12004654
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of radiation side effects with oral pilocarpine.
    Schuller DE; Stevens P; Clausen KP; Olsen J; Gahbauer R; Martin M
    J Surg Oncol; 1989 Dec; 42(4):272-6. PubMed ID: 2687586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new medication for treatment of dry mouth in Sjögren's syndrome.
    al-Hashimi I; Taylor SE
    Tex Dent J; 2001 Apr; 118(3):262-6. PubMed ID: 11404944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment with pilocarpine hydrochloride for sicca symptoms in Sjögren's syndrome].
    Takaya M; Ichikawa Y; Yamada C; Hoshina Y; Horiki T; Uchiyama M
    Ryumachi; 1997 Jun; 37(3):453-7. PubMed ID: 9256028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation, prevention and management of radiotherapy-induced xerostomia in head and neck cancer patients.
    de Castro G; Federico MH
    Curr Opin Oncol; 2006 May; 18(3):266-70. PubMed ID: 16552239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of radioprotective effect of pilocarpine ingestion on salivary glands.
    Pimentel MJ; Filho MM; Araújo M; Gomes DQ; DA Costa LJ
    Anticancer Res; 2014 Apr; 34(4):1993-9. PubMed ID: 24692737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study.
    Horiot JC; Lipinski F; Schraub S; Maulard-Durdux C; Bensadoun RJ; Ardiet JM; Bolla M; Coscas Y; Baillet F; Coche-Dequéant B; Urbajtel M; Montbarbon X; Bourdin S; Wibault M; Alfonsi M; Calais G; Desprez P; Pene F; Lapeyre M; Vinke J; Maral J
    Radiother Oncol; 2000 Jun; 55(3):233-9. PubMed ID: 11041775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cevimeline gargle for the treatment of xerostomia in patients with Sjögren's syndrome.
    Takagi Y; Kimura Y; Nakamura T
    Ann Rheum Dis; 2004 Jun; 63(6):749. PubMed ID: 15140789
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of the efficacy of topical oral pilocarpine for postirradiation xerostomia in patients with head and neck carcinoma.
    Hamlar DD; Schuller DE; Gahbauer RA; Buerki RA; Staubus AE; Hall J; Altman JS; Elzinga DJ; Martin MR
    Laryngoscope; 1996 Aug; 106(8):972-6. PubMed ID: 8699911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.